Panoptes Pharma is Drug Discovery in Austria that focus on molecule-based therapies business. Founded in 2013. They cover business area such as Provider, molecule-base therapy, severe eye disease, autoimmune uveitis, adenoviral conjunctivitis, therapeutic potential, additional inflammatory, viral indication, patient, unmet medical need, access, novel eye treatment.
2013
( 11 years old in 2024 )
Molecule-based Therapies
-
Reisnerstraße 34/1
Vienna, 1030
Austria
Private
Providermolecule-base therapysevere eye diseaseautoimmune uveitisadenoviral conjunctivitistherapeutic potentialadditional inflammatoryviral indicationpatientunmet medical needaccessnovel eye treatment
* We use standard office opening hours in near Panoptes Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Panoptes Pharma is Drug Discovery business from Austria that founded in 2013 (11 years old in 2024), Panoptes Pharma business is focusing on Molecule-based Therapies.
Panoptes Pharma headquarter office and corporate office address is located in Reisnerstraße 34/1 Vienna, 1030 Austria.
Panoptes Pharma was founded in Austria.
In 2024, Panoptes Pharma is currently focus on molecule-based therapies sector.
Above is snippet of Google Trends for "molecule-based therapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Panoptes Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
